LISATA THERAPEUTICS, INC. — Director's Dealing 2018

Jan 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2018-01-08

Reporting Person: KLOSK STEVEN M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-08	Restricted Stock Units	$	A	8747	Acquired	2028-01-08	Common Stock (8747)	Direct

Footnotes

F1: Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2: The restricted stock units vest in full on the date that is one year from the date of grant.